Gavin MacBeath

Chief Executive Officer presso TSCAN THERAPEUTICS, INC.

Patrimonio netto: 395 150 $ in data 31/03/2024

54 anni

Health Technology

Consumer Services

Posizioni attive di Gavin MacBeath

Società	Posizione	Inizio	Fine
TSCAN THERAPEUTICS, INC.	Director/Board Member	24/05/2023	-
	Chief Executive Officer	28/03/2023	-
	Chief Operating Officer	01/06/2022	24/05/2023
	Chief Tech/Sci/R&D Officer	01/12/2018	24/05/2023
	Director of Finance/CFO	21/07/2023	29/01/2024

Società	Posizione	Inizio	Fine
ABPRO CORPORATION	Chief Tech/Sci/R&D Officer	01/03/2017	01/07/2018
MERRIMACK PHARMACEUTICALS, INC.	Founder	01/01/1993	01/09/2017
MERRIMACK PHARMACEUTICALS, INC.	Corporate Officer/Principal	13/07/2011	01/09/2017
Harvard University Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA.	Corporate Officer/Principal	01/07/2002	01/06/2010

The Scripps Research Institute	Doctorate Degree
University of Manitoba	Undergraduate Degree

Distribuzione geografica

Stati Uniti	6
Canada	2

Posizioni

Corporate Officer/Principal	2
Chief Tech/Sci/R&D Officer	2
Founder	1

Settori

Health Technology	4
Consumer Services	4

Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Società quotate in Borsa	2
MERRIMACK PHARMACEUTICALS, INC.	Health Technology
TSCAN THERAPEUTICS, INC.	Health Technology

Aziende private	1
Abpro Corp. Abpro Corp. BiotechnologyHealth Technology Abpro Corp. operates as a biotechnology company which develops antibody therapeutics for severe and life threatening diseases. It focusses on novel antibody constructs for immuno-oncology, ophthalmology, and autoimmunity. The company was founded by Ian Chan and Eugene Y. Chan in 2007 and is headquartered in Woburn, MA.	Health Technology